Heptadecan-9-yl 3-(2-{2-[(2-hydroxyethyl)({3-oxo-3-[2-(undecyloxy)ethoxy]propyl})amino]ethoxy}ethoxy)propanoate
Structure Info
- Chemspace ID
- CSSB20957408769 (In-Stock Building Blocks)
- IUPAC Name
- heptadecan-9-yl 3-(2-{2-[(2-hydroxyethyl)({3-oxo-3-[2-(undecyloxy)ethoxy]propyl})amino]ethoxy}ethoxy)propanoate
- Mol formula
- C42H83NO8
- Mol weight
- 730 Da
- Catalog Number(s)
- BBLS20957408769, BP-42564, bbls20957408769
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 10.67
- Heavy atoms count
- 51
- Rotatable bond count
- 44
- Number of rings
- 0
- Carbon bond saturation, Fsp3
- 0.952
- Polar surface area (Å)
- 104
- Hydrogen bond acceptors count
- 7
- Hydrogen bond donors count
- 1
![Chemical structure of Heptadecan-9-yl 3-(2-{2-[(2-hydroxyethyl)({3-oxo-3-[2-(undecyloxy)ethoxy]propyl})amino]ethoxy}ethoxy)propanoate (C42H83NO8) - CSSB20957408769](/st/structure/200/ba2cfb8cf935e36f44776967c514167f/CCCCCCCCCCCOCCOC%2528%253DO%2529CCN%2528CCO%2529CCOCCOCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png "C42H83NO8")
- Zoom the structure
- CSSB20957408769
Items Overall 9 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 5 days | United States To: | 95 | 50 umol | 342.14 | |
| BB4LS US | 5 days | United States To: | 95 | 100 umol | 598.95 | |
| BB4LS US | 5 days | United States To: | 95 | 200 umol | 953.57 | |
| BB4LS US | 5 days | United States To: | 95 | 300 umol | 970.60 | |
| BB4LS US | 5 days | United States To: | 95 | 500 umol | 1,837.44 | |
| Broadpharm | 20 days | United States To: | 95 | 50 mg | 352.00 | |
| Broadpharm | 20 days | United States To: | 95 | 100 mg | 605.00 | |
| Broadpharm | 20 days | United States To: | 95 | 250 mg | 946.00 | |
| Broadpharm | 20 days | United States To: | 95 | 1 g | 1,760.00 | |
Description: BP Lipid 466 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 1-heptadecan-9-yl 19-(2-{2-[2-(undecyloxy)ethoxy]ethoxy}ethyl) 16-(2-hydroxyethyl)-4,7,10,13-tetraoxa-16-azanonadecanedioate - CSSB20957408768](/st/structure/200/9e799939bffd4a27580aef6bcfd635f3/CCCCCCCCCCCOCCOCCOCCOC%2528%253DO%2529CCN%2528CCO%2529CCOCCOCCOCCOCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
![Chemical structure of heptadecan-9-yl 8-[(2-hydroxyethyl)(3-oxo-3-{2-[2-(pentyloxy)ethoxy]ethoxy}propyl)amino]octanoate - CSSB20957408763](/st/structure/200/2e70c9b855c91930c2e80864df677c47/CCCCCCCCC%2528CCCCCCCC%2529OC%2528%253DO%2529CCCCCCCN%2528CCO%2529CCC%2528%253DO%2529OCCOCCOCCCCC.png)
![Chemical structure of heptadecan-9-yl 8-[(2-hydroxyethyl)({3-oxo-3-[2-(undecyloxy)ethoxy]propyl})amino]octanoate - CSSB20957408751](/st/structure/200/46d0897953e0c3f3cf50399cc49b69b9/CCCCCCCCCCCOCCOC%2528%253DO%2529CCN%2528CCO%2529CCCCCCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
![Chemical structure of heptadecan-9-yl 8-[(2-hydroxyethyl)[3-oxo-3-(2-{2-[2-(undecyloxy)ethoxy]ethoxy}ethoxy)propyl]amino]octanoate - CSSB14863683092](/st/structure/200/628740ee9373acd78db949587af113f3/CCCCCCCCCCCOCCOCCOCCOC%2528%253DO%2529CCN%2528CCO%2529CCCCCCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
![Chemical structure of undecyl 6-[(2-{2-[3-(heptadecan-9-yloxy)-3-oxopropoxy]ethoxy}ethyl)(2-hydroxyethyl)amino]hexanoate - CSSB20957408737](/st/structure/200/9da96353f8786e49005a13eb9a599465/CCCCCCCCCCCOC%2528%253DO%2529CCCCCN%2528CCO%2529CCOCCOCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
![Chemical structure of heptadecan-9-yl 8-[(2-hydroxyethyl)({6-oxo-6-[2-(undecyloxy)ethoxy]hexyl})amino]octanoate - CSSB20957408765](/st/structure/200/33149e96b8288e373092bd2914238c2b/CCCCCCCCCCCOCCOC%2528%253DO%2529CCCCCN%2528CCO%2529CCCCCCCC%2528%253DO%2529OC%2528CCCCCCCC%2529CCCCCCCC.png)
